Clinical trial
Positron Emission Tomography of Amyloid in Alzheimer's Disease
NCT00205621 · Amsterdam UMC, location VUmc, Other · Suspended
Key facts
| NCT number | NCT00205621 |
|---|---|
| Title | Positron Emission Tomography of Amyloid in Alzheimer's Disease |
| Official title | Positron Emission Tomography of Cerebral Amyloid Load as a Potential Diagnostic Marker for Pre-Symptomatic Alzheimer's Disease. |
| Lead sponsor | Amsterdam UMC, location VUmc, Other |
| Status | Suspended |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Device |
| Interventions | Positron Emission Tomography |
| Enrollment | 50 |
| Start date | Oct 1, 2005 |
| Completion | Dec 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 8, 2006 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: